Men with prostate cancer are being given false hope by tests that underestimate the aggressiveness of their disease, a study suggests.
Researchers found that more than half of a group of men whose cancers were initially classified as slow-growing and confined turned out to have more dangerous tumours.
The findings, published in the British Journal Of Cancer, call into question the ability of experts to grade and stage prostate cancers on the basis of biopsy samples.
It also casts doubt on the "active surveillance" strategy of avoiding unnecessary radical treatment for patients with slow-growing prostate cancer.
Instead, these patients are often closely monitored but left alone until tests suggest their condition has worsened.
More top news
At least two people have died and more than 120 others have been injured after an earthquake rocked Turkey and the Greek island of Kos.
The son Cecil the lion, whose 2015 killing prompted an international outcry, has also been fatally shot during a hunt.
Thickening cloud and rain stalling across Wales and southwest England through tomorrow